Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth


January 6, 2011
114 Pages - SKU: XGBR6060613
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Introduction
2.1 Influenza
2.2 GBI Research Report Guidance
3 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Market Overview
3.1 Production Cycle for the Seasonal Influenza Vaccines
3.2 The Asia-Pacific Region Seasonal Influenza Vaccine Market
3.3 Revenue Forecasts for the Seasonal Influenza Vaccine Market
3.4 Geographical Segmentation
4 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Geographical Landscape
4.1 Revenue Analysis by Geography
4.2 Australia
4.2.1 Vaccination Pattern
4.2.2 Cost of Vaccine
4.2.3 Total Revenue
4.3 New Zealand
4.3.1 Vaccination Pattern
4.3.2 Cost of Vaccine
4.3.3 Total Revenue
4.3.4 Major Players by Market Share
4.4 Taiwan
4.4.1 Vaccination Pattern
4.4.2 Cost of Vaccine
4.4.3 Total Revenue
4.4.4 Major Players by Market Share
4.5 Philippines
4.5.1 Vaccination Pattern
4.5.2 Cost of Vaccine
4.5.3 Total Revenue
4.5.4 Major Players by Market Share
4.6 Malaysia
4.6.1 Vaccination Pattern
4.6.2 Cost of Vaccine
4.6.3 Total Revenue
4.6.4 Major Players by Market Share
4.7 Hong Kong
4.7.1 Vaccination Pattern
4.7.2 Cost of Vaccine
4.7.3 Total Revenue
4.7.4 Major Players by Market Share
4.8 Singapore
4.8.1 Vaccination Pattern
4.8.2 Cost of Vaccine
4.8.3 Total Revenue
4.8.4 Major Players by Market Share
5 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Drivers and Restraints
5.1 Drivers for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region
5.1.1 Threat of Pandemic Influenza
5.1.2 Increasing Vaccination Coverage for Seasonal Influenza Vaccines
5.1.3 Emergence of Novel Production Technologies and Vaccines
5.1.4 Population Growth
5.1.5 Economic Reasons
5.2 Restraints for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region
5.2.1 Entry Barriers in the Seasonal Influenza Vaccine Market
5.2.2 Variable Demand
5.2.3 Limited Production Capacity
5.3 Australia
5.3.1 Drivers
5.3.2 Restraints
5.4 New Zealand
5.4.1 Drivers
5.4.2 Restraints
5.5 Taiwan
5.5.1 Drivers
5.5.2 Restraints
5.6 Philippines
5.6.1 Drivers
5.6.2 Restraints
5.7 Malaysia
5.7.1 Drivers
5.7.2 Restraints
5.8 Hong Kong
5.8.1 Drivers
5.8.2 Restraints
5.9 Singapore
5.9.1 Drivers
5.9.2 Restraints
6 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Regulatory Landscape
6.1 Registration Process and Regulations in Australia
6.2 Registration Process and Regulations in New Zealand
6.3 Registration Process and Regulations in Taiwan
6.4 Registration Process and Regulations in the Philippines
6.5 Registration Process and Regulations in Malaysia
6.6 Registration Process and Regulations in Hong Kong
6.7 Registration Process and Regulations in Singapore
7 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Pipeline Analysis
7.1 Seasonal Influenza Vaccines - Promising Vaccines under Clinical Development
7.2 Profiles for Promising Vaccines under Clinical Development
7.2.1 Optaflu
7.2.2 GSK2186877A
7.2.3 Intanza / Flu-ID
7.2.4 Fluad Pediatric
7.3 Research and Development Pipeline
8 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Competitive Landscape
8.1 Major Seasonal Influenza Vaccines Marketed in the APAC Region
8.1.1 Fluarix
8.1.2 Vaxigrip
8.1.3 Influvac
8.1.4 Fluvax
8.1.5 Agrippal
8.2 Key Areas Focused for R&D
8.3 Competitive Profiling
8.3.1 Sanofi Pasteur
8.3.2 GlaxoSmithKline Biologicals
8.3.3 Abbott Laboratories (Solvay Pharmaceuticals)
8.3.4 CSL Biotherapies
8.3.5 Novartis Vaccines
8.3.6 Adimmune Corporation
8.3.7 Crucell N.V. (Berna Biotech)
9 Seasonal Influenza Vaccine Market in Asia-Pacific Region: M&A Landscape
9.1 Overview
9.1.1 AstraZeneca Acquires Medimmune
9.1.2 Sanofi Aventis Acquires Acambis
9.1.3 Mymetics Acquires Virosome Biologicals
9.1.4 Simcere Pharmaceutical Acquires a Majority Stake in Jiangsu Yanshen Biological Technology Stock
9.1.5 Novartis to Acquire a Majority Stake in Zhejiang Tianyuan
9.1.6 Abbott Laboratories Acquires Solvay Pharmaceuticals
9.1.7 Nutri Pharma Acquires a Majority Stake in Bionor Immuno
9.1.8 Johnson & Johnson to Acquire a Majority Stake in Crucell
9.2 M&A Deals by Value
9.3 M&A Deals by Geography
9.4 R&D Licensing Agreements for the Period 2007-2010
9.4.1 Crucell Enters Into License Agreement With ADImmune
9.4.2 MedImmune Enters Into Licensing Agreement With Sanofi Pasteur
9.4.3 Vivalis Enters Into Licensing Agreement With GlaxoSmithKline
9.4.4 Vivalis Enters Into Licensing Agreement With Nobilon International
9.4.5 MedImmune Enters Into Licensing Agreement With GlaxoSmithKline
9.4.6 Hemispherx Biopharma Enters Into Licensing Agreement With BIKEN
9.4.7 MedImmune Enters Into Licensing Agreement With BIKEN
9.4.8 MedImmune Enters Into Licensing Agreement With Omninvest
9.4.9 OPKO Health Enters Into Licensing Agreement With Academia Sinica
9.4.10 AltraVax Enters Into Licensing Agreement With Maxygen
9.4.11 NasVax Announces Option Licensing Agreement With Novartis
9.4.12 iBio Enters Into Licensing Agreement With G-Con
9.4.13 Deals by Geography
10 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Research Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
10.3.4 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Sources
1.1 List of Tables
Table 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue ($m), 2009-2016
Table 2: Seasonal Influenza Vaccine Market, APAC Region, Country Wise Revenue ($m), 2009-2016
Table 3: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 4: Seasonal Influenza Vaccine Market, Australia, Overall Vaccination Coverage (Thousands), 2009-2016
Table 5: Seasonal Influenza Vaccine Market, Australia, Vaccination Coverage Break-up by Age Groups (Thousand), 2009-2016
Table 6: Seasonal Influenza Vaccine Market, Australia, Overall Number of Doses (Thousands), 2009-2016
Table 7: Seasonal Influenza Vaccine Market, Australia, Number of Doses by Age Groups, (Thousands), 2009-2016
Table 8: Seasonal Influenza Vaccine Market, Australia, Revenue ($m), 2009-2016
Table 9: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 10: Seasonal Influenza Vaccine Market, New Zealand, Overall Vaccination Coverage (Thousands), 2009-2016
Table 11: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 12: Seasonal Influenza Vaccine Market, New Zealand, Overall Number of Doses (Thousands), 2009-2016
Table 13: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses by Age Groups (Thousands), 2009-2016
Table 14: Seasonal Influenza Vaccine Market, New Zealand, Revenues ($000s), 2009-2016
Table 15: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 16: Seasonal Influenza Vaccine Market, Taiwan, Overall Vaccination Coverage (Thousands), 2009-2016
Table 17: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 18: Seasonal Influenza Vaccine Market, Taiwan, Overall Number of Doses (Thousands), 2009-2016
Table 19: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses by Age Groups (Thousands), 2009-2016
Table 20: Seasonal Influenza Vaccine Market, Taiwan, Revenues ($m), 2009-2016
Table 21: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 22: Seasonal Influenza Vaccine Market, Philippines, Overall Vaccination Coverage (Thousands), 2009-2016
Table 23: Seasonal Influenza Vaccine Market, Philippines, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 24: Seasonal Influenza Vaccine Market, Philippines, Overall Number of Doses (Thousands), 2009-2016
Table 25: Seasonal Influenza Vaccine Market, Philippines, Number of Doses by Age Groups (Thousands), 2009-2016
Table 26: Seasonal Influenza Vaccine Market, Philippines, Revenues ($m), 2009-2016
Table 27: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 28: Seasonal Influenza Vaccine Market, Malaysia, Overall Vaccination Coverage (Thousands), 2009-2016
Table 29: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 30: Seasonal Influenza Vaccine Market, Malaysia, Overall Number of Doses (Thousands), 2009-2016
Table 31: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses by Age Groups (Thousands), 2009-2016
Table 32: Seasonal Influenza Vaccine Market, Malaysia, Revenues ($m), 2009-2016
Table 33: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 34: Seasonal Influenza Vaccine Market, Hong Kong, Overall Vaccination Coverage (Thousands), 2009-2016
Table 35: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 36: Seasonal Influenza Vaccine Market, Hong Kong, Overall Number of Doses (Thousands), 2009-2016
Table 37: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses by Age Groups (Thousands), 2009-2016
Table 38: Seasonal Influenza Vaccine Market, Hong Kong, Revenues ($m), 2009-2016
Table 39: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Table 40: Seasonal Influenza Vaccine Market, Singapore, Overall Vaccination Coverage (Thousands), 2009-2016
Table 41: Seasonal Influenza Vaccine Market, Singapore, Vaccination Coverage by Age Groups (Thousands), 2009-2016
Table 42: Seasonal Influenza Vaccine Market, Singapore, Overall Number of Doses (Thousands), 2009-2016
Table 43: Seasonal Influenza Vaccine Market, Singapore, Number of Doses by Age Groups (Thousands), 2009-2016
Table 44: Seasonal Influenza Vaccine Market, Singapore, Revenues ($m), 2009-2016
Table 45: Seasonal Influenza Vaccine Market, Most Promising Vaccines Under Clinical Development, 2010
Table 46: Seasonal Influenza Vaccine Market, Asia-Pacific Region, Pipeline, Filed in the US, 2010
Table 47: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase III Clinical Pipeline, 2010
Table 48: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase II Clinical Pipeline, 2010
Table 49: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase I Clinical Pipeline, 2010
Table 50: Seasonal Influenza Vaccines, Asia-Pacific Region, Pre-Clinical Pipeline, 2010
Table 51: Seasonal Influenza Vaccines, Asia-Pacific Region, Discovery Phase Pipeline
Table 52: Seasonal Influenza Vaccine Market, Asia-Pacific, Major M&A Deals, 2007-2010
1.2 List of Figures
Figure 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue ($m), 2009-2016
Figure 2: Seasonal Influenza Vaccine Market, APAC Region, Country Wise Market Share (%), 2009 and 2016
Figure 3: Seasonal Influenza Vaccine Market, Australia, Population (Thousands), 2009-2016
Figure 4: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 5: Seasonal Influenza Vaccine Market, Australia, Number of Doses by Age Groups, (Thousands), 2009-2016
Figure 6: Seasonal Influenza Vaccine Market, Australia, Revenue ($m), 2009-2016
Figure 7: Seasonal Influenza Vaccine Market, Australia, Break-up of Revenues ($m), 2009-2016
Figure 8: Seasonal Influenza Vaccine Market, New Zealand, Population (Thousands), 2009-2016
Figure 9: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 10: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 11: Seasonal Influenza Vaccine Market, New Zealand, Revenues ($m), 2009-2016
Figure 12: Seasonal Influenza Vaccine Market, New Zealand, Break-up of Revenues ($m), 2009-2016
Figure 13: Seasonal Influenza Vaccine Market, New Zealand, Market Share for Top Manufacturers, (%), 2009
Figure 14: Seasonal Influenza Vaccine Market, Taiwan, Population (Thousands), 2009-2016
Figure 15: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 16: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 17: Seasonal Influenza Vaccine Market, Taiwan, Revenues ($m), 2009-2016
Figure 18: Seasonal Influenza Vaccine Market, Taiwan, Break-up of Revenues ($m), 2009-2016
Figure 19: Seasonal Influenza Vaccine Market, Taiwan, Market Share for Top Manufacturers, (%), 2009
Figure 20: Seasonal Influenza Vaccine Market, Philippines, Population (Thousands), 2009-2016
Figure 21: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 22: Seasonal Influenza Vaccine Market, Philippines, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 23: Seasonal Influenza Vaccine Market, Philippines, Revenues ($m), 2009-2016
Figure 24: Seasonal Influenza Vaccine Market, Philippines, Break-up of Revenues ($m), 2009-2016
Figure 25: Seasonal Influenza Vaccine Market, Philippines, Market Share for Top Manufacturers, (%), 2009
Figure 26: Seasonal Influenza Vaccine Market, Malaysia, Population (Thousands), 2009-2016
Figure 27: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 28: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 29: Seasonal Influenza Vaccine Market, Malaysia, Revenues ($m), 2009-2016
Figure 30: Seasonal Influenza Vaccine Market, Malaysia, Break-up of Revenues ($m), 2009-2016
Figure 31: Seasonal Influenza Vaccine Market, Malaysia, Market Share for Top Manufacturers, (%), 2009
Figure 32: Seasonal Influenza Vaccine Market, Hong Kong, Population (Thousands), 2009-2016
Figure 33: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 34: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 35: Seasonal Influenza Vaccine Market, Hong Kong, Revenues ($m), 2009-2016
Figure 36: Seasonal Influenza Vaccine Market, Hong Kong, Break-up of Revenues ($m), 2009-2016
Figure 37: Seasonal Influenza Vaccine Market, Hong Kong, Market Share for Top Manufacturers, (%), 2009
Figure 38: Seasonal Influenza Vaccine Market, Singapore, Population (Thousands), 2009-2016
Figure 39: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Contribution by Age Groups (%), 2009-2016
Figure 40: Seasonal Influenza Vaccine Market, Singapore, Number of Doses by Age Groups (Thousands), 2009-2016
Figure 41: Seasonal Influenza Vaccine Market, Singapore, Revenues ($m), 2009-2016
Figure 42: Seasonal Influenza Vaccine Market, Singapore, Break-up of Revenues ($m), 2009-2016
Figure 43: Seasonal Influenza Vaccine Market, Singapore, Market Share for Top Manufacturers, (%), 2009
Figure 44: Seasonal Influenza Vaccine Market, APAC Region, Drivers and Restraints, 2009-2016
Figure 45: Total Detections of Influenza Virus in APAC Countries during 2000-2010
Figure 46: Increase in Influenza Cases Due to H1N1 Pandemic Influenza in 2009
Figure 47: Increasing Vaccination Coverage Against Seasonal Influenza
Figure 48: Vaccination Coverage Rates Forecasts for APAC Region, (%), 2009-2016
Figure 49: Regulatory Authorities in Australia
Figure 50: Drug Approval Process in Australia
Figure 51: Regulatory Authorities in New Zealand
Figure 52: Drug Approval Process in New Zealand
Figure 53: Regulatory Authorities in Taiwan
Figure 54: Drug Approval Process in Taiwan
Figure 55: Regulatory Authorities in the Philippines
Figure 56: Drug Approval Process in Philippines
Figure 57: Regulatory Authorities in Malaysia
Figure 58: Drug Approval Process in Malaysia
Figure 59: Regulatory Authorities in Hong Kong
Figure 60: Drug Approval Process in Hong Kong
Figure 61: Regulatory Authorities in Singapore
Figure 62: Drug Approval Process in Singapore
Figure 63: Seasonal Influenza Vaccine Market, Asia-Pacific Region, R&D Pipeline by Phase (%), 2010
Figure 64: Seasonal Influenza Vaccine Market, Asia-Pacific Region, Clinical Pipeline by Class of Vaccine (%), 2010
Figure 65: Seasonal Influenza Vaccine Market, Product Pipeline of Major Players in Asia-Pacific Region, 2010
Figure 66: Seasonal Influenza Vaccine Market, M&A Deals by Value, (%), 2007-2010
Figure 67: Seasonal Influenza Vaccine Market, M&A Deals by Geography, (%), 2007-2010
Figure 68: Seasonal Influenza Vaccine Market, Major R&D and Licensing Agreements by Geography, (%), 2007-2010
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Pandemic Vaccines Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!